603108 润达医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.8151.2806.69111.36511.408
总资产报酬率 ROA (%)-1.1530.3861.8963.1493.427
投入资产回报率 ROIC (%)-1.4340.4842.4384.0574.315

边际利润分析
销售毛利率 (%)21.51725.36526.55427.99026.998
营业利润率 (%)-1.0924.2607.0717.7798.779
息税前利润/营业总收入 (%)2.6837.92810.62910.89412.100
净利润/营业总收入 (%)-2.3952.2794.8396.2426.752

收益指标分析
经营活动净收益/利润总额(%)63.13991.73975.566103.84189.673
价值变动净收益/利润总额(%)-108.25231.78235.39016.72017.666
营业外收支净额/利润总额(%)6.923-2.4651.3350.4000.341

偿债能力分析
流动比率 (X)1.2011.2201.2481.1541.204
速动比率 (X)0.9721.0441.0650.9640.961
资产负债率 (%)61.60160.82561.93465.49463.450
带息债务/全部投入资本 (%)60.13359.92760.04463.45261.096
股东权益/带息债务 (%)62.25562.95863.12155.09559.836
股东权益/负债合计 (%)48.70250.04548.29340.89245.416
利息保障倍数 (X)0.6962.1023.0703.5333.676

营运能力分析
应收账款周转天数 (天)255.535232.505225.516165.206136.520
存货周转天数 (天)98.08278.35480.18674.27673.918